Rationale of Technical Requirements for NRG-BR001: The First NCI-Sponsored Trial of SBRT for the Treatment of Multiple Metastases

INTRODUCTION: In 2014, the NRG Oncology Group initiated the first NCI-sponsored, phase I clinical trial of SBRT for the treatment of multiple metastases in multiple organ sites (XXXX; NCTXXX). The primary endpoint is to test the safety of SBRT for the treatment of multiple lesions (2–4) in several a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pract Radiat Oncol
Main Authors: Al-Hallaq, Hania A, Chmura, Steven, Salama, Joseph K, Winter, Kathryn A, Robinson, Clifford G, Pisansky, Thomas M, Borges, Virginia, Lowenstein, Jessica L, McNulty, Susan, Galvin, James M, Followill, David S, Timmerman, Robert D, White, Julia R, Xiao, Ying, Matuszak, Martha M
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099083/
https://ncbi.nlm.nih.gov/pubmed/27345129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prro.2016.05.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados